<?xml version="1.0" encoding="UTF-8"?>
<p>Various adaptogens and their active principles—for example, salidroside,
 <xref rid="med21743-bib-0320" ref-type="ref">
  <sup>320</sup>
 </xref>, 
 <xref rid="med21743-bib-0321" ref-type="ref">
  <sup>321</sup>
 </xref>, 
 <xref rid="med21743-bib-0322" ref-type="ref">
  <sup>322</sup>
 </xref>, 
 <xref rid="med21743-bib-0323" ref-type="ref">
  <sup>323</sup>
 </xref>, 
 <xref rid="med21743-bib-0324" ref-type="ref">
  <sup>324</sup>
 </xref>, 
 <xref rid="med21743-bib-0325" ref-type="ref">
  <sup>325</sup>
 </xref>, 
 <xref rid="med21743-bib-0326" ref-type="ref">
  <sup>326</sup>
 </xref> schisandrin A,
 <xref rid="med21743-bib-0327" ref-type="ref">
  <sup>327</sup>
 </xref> schisandrin B,
 <xref rid="med21743-bib-0328" ref-type="ref">
  <sup>328</sup>
 </xref> withaferin A,
 <xref rid="med21743-bib-0329" ref-type="ref">
  <sup>329</sup>
 </xref>, 
 <xref rid="med21743-bib-0330" ref-type="ref">
  <sup>330</sup>
 </xref>, 
 <xref rid="med21743-bib-0331" ref-type="ref">
  <sup>331</sup>
 </xref>, 
 <xref rid="med21743-bib-0332" ref-type="ref">
  <sup>332</sup>
 </xref>, 
 <xref rid="med21743-bib-0333" ref-type="ref">
  <sup>333</sup>
 </xref>, 
 <xref rid="med21743-bib-0334" ref-type="ref">
  <sup>334</sup>
 </xref> Ginsenoside 20(S)‑Rg3,
 <xref rid="med21743-bib-0335" ref-type="ref">
  <sup>335</sup>
 </xref> Ginsenoside 20(S)‐Rh2,
 <xref rid="med21743-bib-0336" ref-type="ref">
  <sup>336</sup>
 </xref> compound K,
 <xref rid="med21743-bib-0337" ref-type="ref">
  <sup>337</sup>
 </xref>, 
 <xref rid="med21743-bib-0338" ref-type="ref">
  <sup>338</sup>
 </xref> and 20(S)‐25‐methoxy‐protopanaxatriol
 <xref rid="med21743-bib-0339" ref-type="ref">
  <sup>339</sup>
 </xref>, 
 <xref rid="med21743-bib-0340" ref-type="ref">
  <sup>340</sup>
 </xref>—exhibit anticancer effects in various in vitro and in vivo models of breast, colorectal, prostate, hepatic, and intestinal cancers, and so forth by interacting with multiple intracellular signaling pathways, including the inhibition of proinflammatory pathways, such as the ERK/MAPK
 <xref rid="med21743-bib-0341" ref-type="ref">
  <sup>341</sup>
 </xref> and STAT3 signaling pathways.
 <xref rid="med21743-bib-0320" ref-type="ref">
  <sup>320</sup>
 </xref>, 
 <xref rid="med21743-bib-0321" ref-type="ref">
  <sup>321</sup>
 </xref>, 
 <xref rid="med21743-bib-0322" ref-type="ref">
  <sup>322</sup>
 </xref>, 
 <xref rid="med21743-bib-0323" ref-type="ref">
  <sup>323</sup>
 </xref>, 
 <xref rid="med21743-bib-0324" ref-type="ref">
  <sup>324</sup>
 </xref>, 
 <xref rid="med21743-bib-0325" ref-type="ref">
  <sup>325</sup>
 </xref>, 
 <xref rid="med21743-bib-0326" ref-type="ref">
  <sup>326</sup>
 </xref>, 
 <xref rid="med21743-bib-0327" ref-type="ref">
  <sup>327</sup>
 </xref>, 
 <xref rid="med21743-bib-0328" ref-type="ref">
  <sup>328</sup>
 </xref>, 
 <xref rid="med21743-bib-0329" ref-type="ref">
  <sup>329</sup>
 </xref>, 
 <xref rid="med21743-bib-0330" ref-type="ref">
  <sup>330</sup>
 </xref>, 
 <xref rid="med21743-bib-0331" ref-type="ref">
  <sup>331</sup>
 </xref>, 
 <xref rid="med21743-bib-0332" ref-type="ref">
  <sup>332</sup>
 </xref>, 
 <xref rid="med21743-bib-0333" ref-type="ref">
  <sup>333</sup>
 </xref>, 
 <xref rid="med21743-bib-0334" ref-type="ref">
  <sup>334</sup>
 </xref>, 
 <xref rid="med21743-bib-0335" ref-type="ref">
  <sup>335</sup>
 </xref>, 
 <xref rid="med21743-bib-0336" ref-type="ref">
  <sup>336</sup>
 </xref>, 
 <xref rid="med21743-bib-0337" ref-type="ref">
  <sup>337</sup>
 </xref>, 
 <xref rid="med21743-bib-0338" ref-type="ref">
  <sup>338</sup>
 </xref>, 
 <xref rid="med21743-bib-0339" ref-type="ref">
  <sup>339</sup>
 </xref>, 
 <xref rid="med21743-bib-0340" ref-type="ref">
  <sup>340</sup>
 </xref>
</p>
